/C O R R E C T I O N -- SuperGen, Inc.; MGI PHARMA, INC./
01 Octubre 2004 - 9:49AM
PR Newswire (US)
/C O R R E C T I O N -- SuperGen, Inc.; MGI PHARMA, INC./ In the
news release, SuperGen and MGI PHARMA Announce Filing of MAA for
Approval of Dacogen(TM) in Europe, issued earlier today by
SuperGen, Inc. and MGI PHARMA, INC. over PR Newswire, we are
advised by a representative of the companies that the headline
should read "SuperGen and MGI PHARMA Announce Submission of MAA for
Approval of Dacogen(TM) in Europe" rather than "SuperGen and MGI
PHARMA Announce Filing of MAA for Approval of Dacogen(TM) in
Europe" as originally issued inadvertently. PRNewswire -- Oct. 1
DATASOURCE: SuperGen, Inc.; MGI PHARMA, INC.
Copyright